| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $204.5M | +34.6% |
| Cost of Revenue | $195.4M | +0.4% |
| Gross Profit | $9.1M | +121.2% |
| R&D Expense | $43.5M | +26.5% |
| SG&A Expense | $104.6M | +2.9% |
| Operating Income | -$159.9M | +17.6% |
| Interest Expense | $3.3M | -38.6% |
| Pre-tax Income | -$158.2M | +23.4% |
| Income Tax | $33K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $231.4M | -51.9% |
| Short-term Investments | $25.1M | — |
| Accounts Receivable | $119.3M | +34.5% |
| Inventory | $84.3M | +57.7% |
| Current Assets | $545.1M | -22.9% |
| Total Assets | $985.0M | -1.0% |
| Current Liabilities | $252.4M | +43.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.9M | -19.7% |
| Capital Expenditures | $150.9M | +71.7% |
| Investing Cash Flow | -$175.9M | -100.3% |
| Financing Cash Flow | $5.0M | -99.2% |
| Free Cash Flow | -$204.8M | -54.1% |
| — |
| Net Income | -$158.2M | +23.4% |
| EPS (Basic) | -$0.52 | +58.7% |
| EPS (Diluted) | -$0.52 | +58.7% |
| Long-term Debt |
| $29.0M |
| — |
| Total Liabilities | $372.0M | +20.5% |
| Stockholders' Equity | $613.0M | -10.7% |